īther NeuroAlly™ · 5 mg · 30 capsules · a one-month supply.
One daily capsule of KGA-10™ (Mycolicibacterium petrae) — the strain from the 2026 clinical trial, at 5 mg.
Currently out of stock. Join the list below and we'll email you the moment it's back.
Leave your email and you'll be first to know when the next batch ships. One email when it's back — nothing else.
You're on the list. We'll email you the moment it's back.
*Clinical trial results refer to KGA-10™ at the 1 mg dose, in a 60-person randomized, double-blind, placebo-controlled trial in healthy adults, 2026. The 5 mg dose was not the dose evaluated in that trial.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
One capsule a day was the protocol in the trial. A subscription matches it — 20% off every shipment, free domestic shipping, and you can pause, skip, or cancel from your account in under a minute.
NeuroAlly™ is produced in characterized batches. When inventory tightens, subscription members are allocated first — so when the next batch ships, the restock list gets the email and members get the supply.
We don't use manufactured scarcity, stock-level alarms, or countdown clocks. Allocation is decided batch by batch.
NeuroAlly™ is produced in characterized batches, so restocks arrive in waves rather than continuously. Add your email to the notify list above and you'll get a single message the moment the next batch is available.
No. NeuroAlly™ is a postbiotic — a heat-killed, non-living preparation of the strain KGA-10™. Shelf-stable, no refrigeration, no CFU counts to debate.
Mechanism. Adaptogens act on the HPA axis and cortisol. KGA-10™ works through the immune-regulatory, the "Old Friends" pathway — a different category entirely. The clinical evidence rests on the 2026 RCT of KGA-10™.
In the clinical trial, 94% of participants reported reduced perceived-stress scores within 2 weeks. Individual response varies.
One capsule daily, any time of day, with or without food. The trial protocol used once-daily dosing.
Yes. NeuroAlly™ engages a separate pathway and is designed to be compatible with most protocols. Consult your physician if you have specific conditions or take prescription medication.
Every batch is tested for identity, purity, and contaminants. Certificates of Analysis are available on request.
Not intended for individuals under 18, pregnant or nursing women, or immunocompromised individuals. Consult your physician before use.